Quality of Life After Prostate Cancer Diagnosis: Data from the Pros-IT CNR.
暂无分享,去创建一个
G. Muto | R. Montironi | R. Corvò | S. Maggi | M. Noale | V. Zagonel | P. Bassi | U. Ricardi | G. Crepaldi | S. Bracarda | W. Artibani | A. Tubaro | M. Gacci | V. Mirone | E. Russi | A. Porreca | G. Conti | S. Magrini | F. Bertoni | P. Graziotti | S. Pecoraro
[1] G. Muto,et al. Pros-IT CNR: an Italian prostate cancer monitoring project , 2017, Aging Clinical and Experimental Research.
[2] S. Serni,et al. Meta-analysis of metabolic syndrome and prostate cancer , 2017, Prostate Cancer and Prostatic Diseases.
[3] G. Muto,et al. QUALITY OF LIFE AT TIME OF DIAGNOSIS OF PROSTATE CANCER: PRELIMINARY RESULTS OF THE PROS-IT CNR STUDY , 2017 .
[4] G. Muto,et al. OC-0146: The PROS-IT CNR study: comorbidities and medications at the time of diagnosis of prostate cancer , 2016 .
[5] G. Muto,et al. 96 Comorbidities and concomitant medications at time of diagnosis of prostate cancer: Data from the PROS-IT CNR study , 2016 .
[6] M. Esposito,et al. Urinary and sexual outcomes in long-term (5+ years) prostate cancer disease free survivors after radical prostatectomy , 2009, Health and quality of life outcomes.
[7] L. Livi,et al. Quality of life after radical treatment of prostate cancer: validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index. , 2005, Urology.